TransCode Therapeutics Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAZ TransCode Therapeutics Inc.

交易中 06-11 10:18:34 EDT

5.17

-0.34

-6.17%

最高5.40	最低5.17	成交量3,936
今开5.27	昨收5.51	日振幅4.17%
总市值491.31万	流通市值430.36万	总股本95.03万
成交额2.10万	换手率0.47%	流通股本83.24万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":5.1701,"timestamp":1781187511482,"preClose":5.51,"halted":0,"volume":3936,"delay":0,"changeRate":-0.061687840290381143,"floatShares":832400,"shares":950300,"eps":-49.890354,"marketStatus":"交易中","change":-0.3399,"latestTime":"06-11 10:18:34 EDT","open":5.27,"high":5.4,"low":5.17,"amount":21006.0411552,"amplitude":0.041742,"askPrice":5.54,"askSize":5,"bidPrice":5.35,"bidSize":38,"shortable":0,"etf":0,"ttmEps":-49.890354,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781208000000},"marketStatusCode":2,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":5.51,"preHourTrading":{"tag":"盘前","latestPrice":5.46,"preClose":5.51,"latestTime":"07:42 EDT","volume":10,"amount":54.6,"timestamp":1781178131470,"change":-0.05,"changeRate":-0.009074,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":5.51,"preClose":5.51,"latestTime":"18:55 EDT","volume":402,"amount":2210.5837,"timestamp":1781132121856,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.435545},"requestUrl":"/m/hq/s/RNAZ","defaultTab":"news","newsList":[{"id":"1129953342","title":"TransCode公司TTX-MC138进入ctDNA阳性结直肠癌IIa期临床开发阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=1129953342","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129953342?lang=zh_cn&edition=full","pubTime":"2026-06-03 20:05","pubTimestamp":1780488323,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司的在研疗法TTX-MC138，在针对循环肿瘤DNA（ctDNA）阳性结直肠癌的临床研究中取得重要进展，现已推进至IIa期开发阶段。这一进展标志着该疗法在探索性治疗领域迈出了关键一步，旨在为特定患者群体提供新的潜在治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157496823","title":"TransCode Therapeutics启动针对ctDNA阳性结直肠癌患者的TTX-MC138二期a临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1157496823","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157496823?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:06","pubTimestamp":1779883565,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司已启动一项二期a阶段临床试验，该试验旨在评估其候选药物TTX-MC138在循环肿瘤DNA（ctDNA）阳性的结直肠癌患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123889583","title":"TransCode Therapeutics提交SEC文件：股东申请转售约1600万股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1123889583","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123889583?lang=zh_cn&edition=full","pubTime":"2026-05-01 05:28","pubTimestamp":1777584491,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司近日向美国证券交易委员会提交文件，披露部分持股股东计划转售该公司普通股，总量最高可达约1600万股。此次转售申请涉及二级市场交易，现有股东拟通过公开市场减持所持股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104376516","title":"TransCode Therapeutics任命安娜·摩尔博士为科学顾问委员会主席，并与密歇根州立大学达成资助研究协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1104376516","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104376516?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:28","pubTimestamp":1777292896,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. (RNAZ) 宣布两项重要科研布局。公司正式任命安娜·摩尔博士担任其科学顾问委员会主席，以期借助其深厚学术背景推动研发战略。与此同时，TransCode Therapeutics还与密歇根州立大学签署了一项资助研究协议，旨在深化特定技术领域的探索合作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189079805","title":"TransCode Therapeutics与Unleash达成协议，后者将获113.6万股优先股","url":"https://stock-news.laohu8.com/highlight/detail?id=1189079805","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189079805?lang=zh_cn&edition=full","pubTime":"2026-03-03 21:13","pubTimestamp":1772543599,"startTime":"0","endTime":"0","summary":"根据双方达成的协议条款，Unleash将获得TransCode Therapeutics发行的1,136,364股优先股。此次股权安排标志着两家公司在战略合作层面取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177229209","title":"TransCode Therapeutics与Quantum Leap联合提交TTX-MC138二期a阶段临床试验IND修正案","url":"https://stock-news.laohu8.com/highlight/detail?id=1177229209","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177229209?lang=zh_cn&edition=full","pubTime":"2026-02-05 21:07","pubTimestamp":1770296876,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics公司与Quantum Leap共同宣布，已正式提交针对TTX-MC138药物的二期a阶段临床试验新药研究申请修正案。该举措标志着双方在推进创新疗法临床开发方面取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605283236","title":"Transcode Therapeutics, Inc.盘中异动 快速拉升7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605283236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605283236?lang=zh_cn&edition=full","pubTime":"2026-01-24 01:43","pubTimestamp":1769190216,"startTime":"0","endTime":"0","summary":"北京时间2026年01月24日01时43分，Transcode Therapeutics, Inc.股票出现异动，股价大幅上涨7.30%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc是一家生物制药公司，专注于开发和商业化用于癌症治疗和诊断的创新药物和诊断工具。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124014337953e20eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260124014337953e20eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","RNAZ","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131967043","title":"TransCode Therapeutics公司预计2026上半年启动TTX-MC138二期a阶段临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1131967043","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131967043?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:15","pubTimestamp":1767705321,"startTime":"0","endTime":"0","summary":"根据最新提交至美国证券交易委员会（SEC）的文件披露，生物技术公司TransCode Therapeutics（股票代码：RNAZ）旗下针对癌症治疗的创新疗法TTX-MC138，计划于2026年上半年进入二期a阶段临床试验。这一进展标志着该疗法在临床开发路径上迈出关键一步，为后续研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592194636","title":"Transcode Therapeutics, Inc.盘中异动 下午盘股价大涨5.29%报8.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592194636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592194636?lang=zh_cn&edition=full","pubTime":"2025-12-20 02:13","pubTimestamp":1766168008,"startTime":"0","endTime":"0","summary":"北京时间2025年12月20日02时13分，Transcode Therapeutics, Inc.股票出现波动，股价大幅上涨5.29%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.61%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc是一家生物制药公司，专注于开发和商业化用于癌症治疗和诊断的创新药物和诊断工具。TransCode最近启动了其首次临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251220021328953b7676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4007","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275610","title":"Transcode Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275610?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613493,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Transcode Therapeutics, Inc.股票出现波动，股价快速拉升5.10%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1825.42%、384.06%、45.95%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、Y-Mabs Therapeutics, Inc.，振幅分别为99.13%、98.72%、94.67%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213133964035b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516823632","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速跳水5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516823632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516823632?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012489,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Transcode Therapeutics, Inc.股票出现异动，股价快速跳水5.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.12%、30.13%、28.75%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、15.49%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223450abe63461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNAZ","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378305","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌5.56%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378305?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:46","pubTimestamp":1740753964,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时46分，Transcode Therapeutics, Inc.股票出现波动，股价大幅下跌5.56%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为512.94%、339.48%、276.30%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Enveric Biosciences, Inc.，振幅分别为45.32%、31.14%、29.25%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822460496341d74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514738591","title":"Transcode Therapeutics, Inc.盘中异动 早盘快速下挫21.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738591?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:36","pubTimestamp":1740666978,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时36分，Transcode Therapeutics, Inc.股票出现波动，股价急速下挫21.79%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为434.17%、92.95%、68.95%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Aurinia Pharmaceuticals Inc，振幅分别为16.59%、15.14%、14.91%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223619abdf6ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNAZ","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013879","title":"Transcode Therapeutics, Inc.盘中异动 股价大跌6.05%报6.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013879?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:58","pubTimestamp":1740495491,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时58分，Transcode Therapeutics, Inc.股票出现波动，股价快速跳水6.05%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Lava Therapeutics N.V.涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为978.61%、734.95%、562.63%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为121.95%、46.65%、43.70%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225225811a2538d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720932","title":"Transcode Therapeutics, Inc.盘中异动 急速下挫7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720932","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720932?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:43","pubTimestamp":1740408215,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时43分，Transcode Therapeutics, Inc.股票出现波动，股价快速下挫7.12%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为84.61%、50.66%、24.62%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Vaxart, Inc. - Common Stock，振幅分别为100.73%、27.99%、21.42%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242243369890f8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242243369890f8db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513291478","title":"Transcode Therapeutics, Inc.盘中异动 早盘股价大跌5.98%报8.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513291478?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:27","pubTimestamp":1740151635,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时27分，Transcode Therapeutics, Inc.股票出现异动，股价大幅下跌5.98%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232715a24ebdcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221232715a24ebdcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512484717","title":"Transcode Therapeutics, Inc.盘中异动 快速下挫5.56%报10.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512484717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512484717?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:41","pubTimestamp":1739983307,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时41分，Transcode Therapeutics, Inc.股票出现异动，股价急速下挫5.56%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为594.07%、245.75%、202.14%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Aditxt, Inc.，振幅分别为207.68%、159.49%、48.18%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004147988b4642&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220004147988b4642&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166055","title":"Transcode Therapeutics, Inc.盘中异动 急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166055?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:56","pubTimestamp":1739890612,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时56分，Transcode Therapeutics, Inc.股票出现异动，股价大幅上涨5.19%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225653988a0241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218225653988a0241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAZ","BK4539","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511694865","title":"Transcode Therapeutics, Inc.盘中异动 早盘大幅跳水5.21%报10.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694865?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:15","pubTimestamp":1739546102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时15分，Transcode Therapeutics, Inc.股票出现波动，股价急速下跌5.21%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2333.27%、609.93%、467.29%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231503abcf1087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231503abcf1087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525045","title":"Transcode Therapeutics, Inc.盘中异动 早盘股价大跌5.19%报10.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525045","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525045?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:36","pubTimestamp":1739457404,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时36分，Transcode Therapeutics, Inc.股票出现异动，股价大幅跳水5.19%。截至发稿，该股报10.22美元/股，成交量6488股，换手率0.93%，振幅3.34%。Transcode Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Transcode Therapeutics, Inc.公司简介：TransCode Therapeutics Inc 是一家临床阶段肿瘤公司，专注于治疗转移性疾病。此外，TransCode 还在开发一流的 RNA 候选疗法产品组合，旨在克服 RNA 递送方面的挑战，从而打开治疗各种新型基因靶点的通道，这些靶点可能与治疗各种癌症相关。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322364598842cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021322364598842cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcodetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0933},{"period":"1month","weight":-0.2129},{"period":"3month","weight":-0.4378},{"period":"6month","weight":-0.4206},{"period":"1year","weight":-0.2524},{"period":"ytd","weight":-0.1933}],"compareEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":-0.0188},{"period":"3month","weight":0.0891},{"period":"6month","weight":0.0641},{"period":"1year","weight":0.2029},{"period":"ytd","weight":0.0638}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TransCode Therapeutics, Inc.于2016年1月11日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，率先开发用于高危和晚期癌症的免疫肿瘤学及RNA疗法。其主要候选药物TTX-MC138是一种靶向致癌微小RNA的反义抑制剂，并通过收购Polynoma扩大了研发管线，后者正在开发用于黑色素瘤的研究性癌症疫苗Seviprotimut-L。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.151744},{"month":2,"riseRate":0.4,"avgChangeRate":-0.217151},{"month":3,"riseRate":0.2,"avgChangeRate":-0.176578},{"month":4,"riseRate":0,"avgChangeRate":-0.095649},{"month":5,"riseRate":0.2,"avgChangeRate":0.100121},{"month":6,"riseRate":0.4,"avgChangeRate":-0.196134},{"month":7,"riseRate":0.5,"avgChangeRate":-0.053703},{"month":8,"riseRate":0.2,"avgChangeRate":-0.126775},{"month":9,"riseRate":0.4,"avgChangeRate":0.103909},{"month":10,"riseRate":0.2,"avgChangeRate":-0.169992},{"month":11,"riseRate":0,"avgChangeRate":-0.238135},{"month":12,"riseRate":0.2,"avgChangeRate":-0.139059}],"exchange":"NASDAQ","name":"TransCode Therapeutics  Inc.","nameEN":"TransCode Therapeutics  Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TransCode Therapeutics  Inc.,RNAZ,TransCode Therapeutics  Inc.股票,TransCode Therapeutics  Inc.股票老虎,TransCode Therapeutics  Inc.股票老虎国际,TransCode Therapeutics  Inc.行情,TransCode Therapeutics  Inc.股票行情,TransCode Therapeutics  Inc.股价,TransCode Therapeutics  Inc.股市,TransCode Therapeutics  Inc.股票价格,TransCode Therapeutics  Inc.股票交易,TransCode Therapeutics  Inc.股票购买,TransCode Therapeutics  Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransCode Therapeutics  Inc.(RNAZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TransCode Therapeutics  Inc.(RNAZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}